Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 2, 2007, Pages

  Bartunek, Jozef ^a   Croissant, Jeffrey D ^b,g   Wijns, William ^a   Gofflot, Stephanie ^c   De Lavareille, Aurore ^d   Vanderheyden, Marc ^a   Kaluzhny, Yulia ^b,h   Mazouz, Naïma ^d   Willemsen, Philippe ^d   Penicka, Martin ^a   Mathieu, Myrielle ^e   Homsy, Christian ^d   De Bruyne, Bernard ^a   McEntee, Kathleen ^e   Lee, Ike W ^d   Heyndrickx, Guy R ^a,f  

^a CARDIOVASCULAR CENTER   (Belgium)

^b Anterogen Research Laboratories   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Cardio NV   (Belgium)

^e FREE UNIVERSITY OF BRUSSELS   (Belgium)

^f Louvain Medical School   (Belgium)

^g Invitrogen Corp   (United States)

^h MATTEK CORPORATION   (United States)

Author keywords

Cardiac repair; Chronic myocardial infarction; Heart failure; Myogenesis

Indexed keywords

BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; DESMIN; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MYOCYTE ENHANCER FACTOR 2 ANTIBODY; MYOSIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR NKX2.5; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL CULTURE; CELL ISOLATION; CELL LINEAGE; CELL SPECIFICITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE MODEL; DOG; EX VIVO STUDY; HEART INFARCTION; HEART MOVEMENT; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAINING;

ADULT STEM CELLS; ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOGS; FIBROBLAST GROWTH FACTORS; HEART VENTRICLES; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; RECOVERY OF FUNCTION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; VENTRICULAR FUNCTION, LEFT;

EID: 33846976185     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01009.2005     Document Type: Article

References (33)

1. Arai A, Yamamoto K, Toyama J. Murine cardiac progenitor cells require visceral embryonic endoderm and primitive streak for terminal differentiation. Dev Dyn 210: 344-353, 1997.
2. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017, 2002.
3. Auda-Boucher G, Bernard B, Fontaine-Perus J, Rouaud T, Mericksay M, Gardahaut M-F. Staging of the commitment of murine cardiac cell progenitors. Dev Biol 225: 214-225, 2000.
4. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haemotopoietic stem cells adopt mature haemotopoietic fates in ischemic myocardium. Nature 428: 668-673, 2004.
5. Bel A, Messas E, Agbulut O, Richard P, Samuel JL, Bruneval P, Hagege AA, Menasche P. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 108: 247-252, 2003.
6. Chien KR. Stem cells: lost in translation. Nature 428: 607-608, 2004.
7. Garcia-Martinez V, Schoenwolf GC. Primitive-streak origin of the cardiovascular system in avian embryos. Dev Biol 159: 706-719, 1993.
8. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem calls derived from adult marrow. Nature 418: 41-49, 2002.
9. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001.
10. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201, 2003.
11. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Myoblast transplantation for heart failure. Lancet 357: 279-280, 2001.
12. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107: 2733-2740, 2003.
13. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haemotopoietic stem cells do not transdifferentiate cardiac myocytes in ischaemic myocardium. Nature 428: 664-668, 2004.
14. Nakamura T, Schneider M. The way to a human's heart is through the stomach. Visceral endoderm-like cells drive human embryonic stem cells to a cardiac fate. Circulation 107: 2638-2639, 2003.
15. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SE. Bone marrow-derived haemotopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10: 494-501, 2004.
16. Olson E. A decade of discoveries in cardiac biology. Nat Med 10: 467-474, 2004.
17. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 9: 1092-1102, 2002.
18. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001.
19. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart disease. Circulation 107: 2294-2302, 2003.
20. Schultheiss TM, Burch JB, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 11: 451-462, 1997.
21. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73: 1919-1926, 2002.
22. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156, 2005.
23. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46, 2003.
24. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation. Circulation 106: 1913-1918, 2002.
25. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation 107: 929-934, 2003.
26. Sugi Y, Lough J. Activin-A and FGF-2 mimic the inductive effects of anterior endoderm on terminal cardiac myogenesis in vitro. Dev Biol 168: 567-574, 1995.
27. Sugi Y, Lough J. Anterior endoderm is a specific effector of terminal cardiac myocyte differentiation of cells from the embryonic heart forming region. Dev Dyn 200: 155-162, 1994.
28. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98, 2002.
29. Tomita S, Li R-K, Weisel RD, Micjke DAG, Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, Suppl: II247-II256, 1999.
30. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y, Liu P, Li RK. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123: 1132-1140, 2002.
31. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120: 999-1005, 2000.
32. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109: 3154-3157, 2004.
33. Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, Neuhuber WL, Weyand M, Eschenhagen T. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106: I151-I157, 2002.